Healthy volunteer studies in Great Britain: the results of a survey into 12 months activity in this field.

Abstract:

:1. A survey has been conducted amongst 459 members of the Clinical Section of the British Pharmacological Society to ascertain facts about the administration of drugs to healthy volunteers over the period October 1986 to September 1987. 2. A response rate of 87.1% was obtained with 114 individuals being involved in healthy volunteer studies. After exclusion of duplicate returns from the same unit 98 questionnaires were analysed. 3. Drugs were given in the year under review to 8163 healthy volunteers for research purposes. Minor adverse effects were reported in 565 (6.9%), moderately severe adverse effects in 45 (0.55%) and potentially life threatening adverse effects in 3 (0.04%). No lasting sequelae were reported. 4. Drugs were given to 7607 healthy student volunteers as part of class teaching practicals. Minor adverse effects were reported in 6.0% of student exposures but no moderately severe or life threatening adverse effects were reported. 5. The risk involved in healthy volunteer studies is very small indeed but some suggestions are made as a result of the questionnaire to improve further the safety of these studies.

journal_name

Br J Clin Pharmacol

authors

Orme M,Harry J,Routledge P,Hobson S

doi

10.1111/j.1365-2125.1989.tb05342.x

subject

Has Abstract

pub_date

1989-02-01 00:00:00

pages

125-33

issue

2

eissn

0306-5251

issn

1365-2125

journal_volume

27

pub_type

杂志文章
  • Effect of sulindac on the cough reflex of healthy subjects.

    abstract::The effects of a single dose of sulindac 200 mg and placebo on the capsaicin-induced cough reflex were studied in a two-phase double-blind crossover study in 18 healthy subjects. Sulindac increased the threshold for capsaicin cough response significantly, but did not alter D5, peak response, or the total cough respons...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1111/j.1365-2125.1991.tb05518.x

    authors: Foster G,Yeo WW,Ramsay LE

    更新日期:1991-02-01 00:00:00

  • A cohort study of the ocular safety of anti-ulcer drugs.

    abstract::1. Recently, some cases have been reported where intravenous use of omeprazole was followed by loss of vision. We followed up a cohort of close to 140,000 persons during periods of treatment and non-treatment with five anti-ulcer drugs. 2. The relative risk of vascular disorders of the eye during use of omeprazole com...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1046/j.1365-2125.1996.40211.x

    authors: García Rodríguez LA,Mannino S,Wallander MA,Lindblom B

    更新日期:1996-08-01 00:00:00

  • Ciprofloxacin absorption in different regions of the human gastrointestinal tract. Investigations with the hf-capsule.

    abstract::1. The absorption of ciprofloxacin from different regions of the human gastrointestinal tract was investigated in four healthy males using a remote-controlled drug delivery device (hf-capsule). 2. Significant differences in AUC were observed in the control study (oral administration of ciprofloxacin solution without t...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1990.tb03740.x

    authors: Harder S,Fuhr U,Beermann D,Staib AH

    更新日期:1990-07-01 00:00:00

  • Intestinal first pass metabolism of midazolam in liver cirrhosis --effect of grapefruit juice.

    abstract:AIMS:Grapefruit juice inhibits CYP3A4 in the intestinal wall leading to a reduced intestinal first pass metabolism and thereby an increased oral bioavailability of certain drugs. For example, it has been shown that the oral bioavailability of midazolam, a CYP3A4 substrate, increased by 52% in healthy subjects after ing...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1046/j.1365-2125.2002.01615.x

    authors: Andersen V,Pedersen N,Larsen NE,Sonne J,Larsen S

    更新日期:2002-08-01 00:00:00

  • TPMT*26 (208F-->L), a novel mutation detected in a Chinese.

    abstract:AIMS:Azathioprine, mercaptopurine and thioguanine are commonly used to treat autoimmune disorders, leukaemia and solid organ transplantation. However, azathiopurine and its metabolites can also cause adverse reactions such as myelosuppression. These manifestations may be attributed to polymorphisms or mutations in the ...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.2009.03405.x

    authors: Kham SK,Soh CK,Aw DC,Yeoh AE

    更新日期:2009-07-01 00:00:00

  • Effect of chronic diuretic treatment on the plasma renin-angiotensin-aldosterone system in essential hypertension.

    abstract::1 Chronic treatment with a constant dose of hydrochlorothiazide or tienilic acid increases plasma renin activity (PRA) acutely to reach a maximum within the first week. 2 During chronic diuretic therapy from 1 month to 1 year, PRA remained elevated at a rather constant level, though this was somewhat lower than the ma...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1981.tb01231.x

    authors: Lijnen P,Fagard R,Staessen J,Amery A

    更新日期:1981-09-01 00:00:00

  • The effect of age on the pharmacokinetics of metoprolol and its metabolites.

    abstract::1 Plasma concentrations of metoprolol and a pharmacologically active metabolite, H119/66, have been measured in young and elderly volunteers after a single dose of 100 mg metoprolol tartrate and after repeated administrated over a period of 1 week. Whilst concentrations of metoprolol are similar in each group, concent...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1981.tb00536.x

    authors: Quarterman CP,Kendall MJ,Jack DB

    更新日期:1981-03-01 00:00:00

  • Decreased systemic clearance of caffeine due to cimetidine.

    abstract::1 Five normal subjects received pre-treatment with cimetidine 200 mg three times daily and 400 mg at night for 6 days, or matching placebo. 2 Caffeine (300 mg) was given orally before any treatment and at the beginning of the last day of each treatment course. Treatments were randomly allocated and separated by at lea...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1111/j.1365-2125.1981.tb01194.x

    authors: Broughton LJ,Rogers HJ

    更新日期:1981-08-01 00:00:00

  • Atenolol elimination in the neonate.

    abstract::The elimination of the cardioselective beta-adrenoceptor antagonist atenolol has been studied in 35 neonates by measuring drug concentration in cord blood and in blood obtained at 24 h by heel stab. Elimination rate was assessed by calculating the slopes of lines joining these two concentration points. The slopes had ...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1983.tb02237.x

    authors: Rubin PC,Butters L,Reynolds B,Evans J,Sumner D,Low RA,Reid JL

    更新日期:1983-12-01 00:00:00

  • Objective outcome criteria in trials of anti-parkinsonian therapy in the elderly: sensitivity, specificity and reliability of measures of brady- and hypo-kinesia.

    abstract::1. We compare the sensitivity and specificity of chosen outcome criteria in a placebo-controlled, randomised cross-over study of the efficacy of maintenance therapy with the levodopa/carbidopa combination (Sinemet Plus) alone. Patients were characterised by having idiopathic Parkinsonism with no overt fluctuations in ...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1111/j.1365-2125.1991.tb05533.x

    authors: Bowes SG,Clark PK,Charlett A,O'Neill CJ,Leeman AL,Weller C,Nicholson PW,Deshmukh AA,Dobbs SM,Dobbs RJ

    更新日期:1991-03-01 00:00:00

  • Pharmacokinetics of co-administered didanosine and stavudine in HIV-seropositive male patients.

    abstract::The pharmacokinetics of single and co-administered didanosine and stavudine were evaluated in 10 HIV-seropositive subjects in an open, within subject design in which each subject received each of three treatments. Single doses of didanosine 100 mg were alternated randomly with single doses of stavudine 40 mg on days 1...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1111/j.1365-2125.1994.tb04374.x

    authors: Seifert RD,Stewart MB,Sramek JJ,Conrad J,Kaul S,Cutler NR

    更新日期:1994-11-01 00:00:00

  • Lack of effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of amlodipine.

    abstract:AIMS:To determine whether repeated once daily administration of grapefruit juice altered the pharmacokinetics or pharmacodynamics of the calcium antagonist amlodipine. METHOD:S The effects of grapefruit juice on the pharmacokinetics and pharmacodynamics of oral and intravenous amlodipine were assessed in 20 healthy me...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1046/j.1365-2125.2000.00283.x

    authors: Vincent J,Harris SI,Foulds G,Dogolo LC,Willavize S,Friedman HL

    更新日期:2000-11-01 00:00:00

  • The pharmacokinetics of ziprasidone in subjects with normal and impaired hepatic function.

    abstract:AIMS:To assess whether hepatic impairment influences the pharmacokinetics of ziprasidone. METHODS:Thirty subjects with normal hepatic function or a primary diagnosis of clinically significant cirrhosis (Child-Pugh A or B) were enrolled into an open-label, multicentre, multiple-dose study. The subjects with chronic, st...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1046/j.1365-2125.2000.00149.x

    authors: Everson G,Lasseter KC,Anderson KE,Bauer LA,Carithens RL Jr,Wilner KD,Johnson A,Anziano RJ,Smolarek TA,Turncliff RZ

    更新日期:2000-01-01 00:00:00

  • Electroencephalographic effects and serum concentrations after intranasal and intravenous administration of diazepam to healthy volunteers.

    abstract:AIMS:To evaluate the electroencephalographic (EEG) effects, blood concentrations, vehicle irritation and dose-effect relationships for diazepam administered nasally. METHODS:The study had a cross-over design with eight healthy volunteers (one drop out). It consisted of four legs with four different administrations: in...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1046/j.0306-5251.2001.01486.x

    authors: Lindhardt K,Gizurarson S,Stefánsson SB,Olafsson DR,Bechgaard E

    更新日期:2001-11-01 00:00:00

  • Propranolol disposition in renal failure.

    abstract::1 Previous studies of propranolol disposition in renal failure have been conflicting. 2 Using simultaneous administration of [3H]-propranolol intravenously and unlabelled propranolol orally the principal determinants of drug distribution were calculated in normals, patients with severe renal impairment (creatinine cle...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1980.tb00511.x

    authors: Wood AJ,Vestal RE,Spannuth CL,Stone WJ,Wilkinson GR,Shand DG

    更新日期:1980-12-01 00:00:00

  • Evaluation of the effect on heart rate variability of a beta2-adrenoceptor agonist and antagonist using non-linear scatterplot and sequence methods.

    abstract:AIMS:To examine the impact on heart rate variability (HRV), of agonism or antagonism at the cardiac beta2-adrenoceptor in healthy volunteers, using standard time-domain summary statistics and non-linear methods (scatterplot and quadrant analysis). METHODS:Under double-blind and randomised conditions (Latin square desi...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1046/j.1365-2125.1999.00862.x

    authors: Hanratty CG,Silke B,Riddell JG

    更新日期:1999-02-01 00:00:00

  • Quality and safety of herbal medical products: regulation and the need for quality assurance along the value chains.

    abstract::Herbal medicines and products derived from them are a diverse group of products for which different (and often limited) levels of evidence are available. As importantly, such products generally vary in their composition and are at the end of an often poorly understood value chain, which often links producers in biodiv...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章,评审

    doi:10.1111/bcp.12586

    authors: Heinrich M

    更新日期:2015-07-01 00:00:00

  • A trial of brolitene in the treatment of spasticity.

    abstract::A new anti-spasticity agent, brolitene, has been assessed in patients with spasticity of spinal or cerebral origin. Twenty-seven patients were entered in a double-blind cross-over trial lasting 6 weeks, using a fixed dose of six tablets (1200 mg brolitene) per day. Clinical assessment failed to show any therapeutic ef...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1111/j.1365-2125.1976.tb00641.x

    authors: Perkin GD,Aminoff MJ

    更新日期:1976-10-01 00:00:00

  • Verapamil disposition--effects of sulphinpyrazone and cimetidine.

    abstract::The effects of separate 7 day pretreatments with sulphinpyrazone (800 mg daily) and cimetidine (1 g daily) on the disposition of (+/-)-verapamil have been examined in eight healthy volunteers (four male, four female). Each subject received single oral (80 mg) and intravenous (0.15 mg/kg) doses of verapamil on differen...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1985.tb02658.x

    authors: Wing LM,Miners JO,Lillywhite KJ

    更新日期:1985-03-01 00:00:00

  • Identification of the cytochrome P450 enzymes involved in the N-demethylation of sildenafil.

    abstract:AIMS:To characterize the cytochrome P450 (CYP) enzymes responsible for the N-demethylation of sildenafil to its main metabolite, UK-103 320, to investigate the potential inhibitory effects of sildenafil on CYP enzymes and to evaluate the potential of selected drugs to affect sildenafil metabolism. METHODS:The metaboli...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1046/j.1365-2125.2001.00318.x

    authors: Hyland R,Roe EG,Jones BC,Smith DA

    更新日期:2001-03-01 00:00:00

  • The evolution of three decades of antiretroviral therapy: challenges, triumphs and the promise of the future.

    abstract::The evolution of human immunodeficiency virus (HIV) treatment has improved our understanding and management of complex pharmacological issues that have driven improved outcomes and quality of life of the HIV-infected patient. These issues include adherence, long- and short-term toxicities, pharmacoenhancement, pharmac...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章,评审

    doi:10.1111/bcp.12403

    authors: Tseng A,Seet J,Phillips EJ

    更新日期:2015-02-01 00:00:00

  • Dose-proportional pharmacokinetics of budesonide inhaled via Turbuhaler.

    abstract:AIMS:The present pharmacokinetic study was undertaken to determine the dose proportionality of three different doses of budesonide-400 microg, 800 microg or 1600 microg administered twice daily by a dry-powder inhaler (Turbuhaler ) in adult patients with mild asthma. METHODS:A total of 38 patients received budesonide ...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1046/j.1365-2125.1999.00008.x

    authors: Kaiser H,Aaronson D,Dockhorn R,Edsbäcker S,Korenblat P,Källén A

    更新日期:1999-09-01 00:00:00

  • Variability of plasma catecholamine levels: age, duration of posture and time of day.

    abstract::1. In order to define factors which influence plasma catecholamine levels, and which might be controlled in the interests of reproducability and comparability, plasma noradrenaline plus adrenaline (NA + A) was measured repeatedly in normal subjects by a double isotope technique. 2. Age and posture were important deter...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1979.tb04718.x

    authors: Saar N,Gordon RD

    更新日期:1979-10-01 00:00:00

  • Tolerance and safety of enalapril.

    abstract::Enalapril is the result of a targeted research programme to develop a non-mercapto converting enzyme inhibitor with a long duration of action and an improved safety profile for use in the therapy of hypertension and congestive heart failure. Over 3500 patients world-wide have received enalapril or enalaprilat. Long-te...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1111/j.1365-2125.1984.tb02604.x

    authors: McFate Smith W,Davies RO,Gabriel MA,Kramsch DM,Moncloa F,Rush JE,Walker JF

    更新日期:1984-01-01 00:00:00

  • Effect of treatment of hypertension in the primary preventive trial, Göteborg, Sweden.

    abstract::1 A treatment group comprising 635 hypertensive men (casual SBP greater than 175 or DBP greater than 115 twice) was compared with a reference group (n = 391 men; casual SBP greater than 175 or DBP greater than 115 only at screening). All men belonged to the same population sample of 7,455 men aged 47-54 yr. 2 The two ...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1979.tb04699.x

    authors: Wilhelmsen L,Berglund G,Sannerstedt R,Hansson L,Andersson O,Sievertsson R,Wikstrand J

    更新日期:1979-01-01 00:00:00

  • Plasma, bone, hip capsule and drain fluid concentrations of ampicillin and flucloxacillin during total hip replacement after intravenous bolus injection of magnapen.

    abstract::1. A rapid intravenous bolus injection of 4.0 g Magnapen (which contains 2.0 g of ampicillin and 2.0 g of flucloxacillin) was to seven patients undergoing total hip replacement immediatly before induction of general anesthesia. Postoperatively the patients patients received 2.0 g Magnapen by intramuscular injection ev...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1978.tb00838.x

    authors: Parsons RL,Beavis JP,Laurence M,David JA,Paddock GM,Trounce JR

    更新日期:1978-08-01 00:00:00

  • The importance of both CYP2C19 and CYP2B6 germline variations in cyclophosphamide pharmacokinetics and clinical outcomes.

    abstract::Cyclophosphamide is an alkylating agent used in the treatment of solid and haematological malignancies and as an immunosuppressive agent. As a prodrug, it is dependent on bioactivation to the active phosphoramide mustard metabolite to elicit its therapeutic effect. This focused review will highlight the evidence for t...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章,评审

    doi:10.1111/bcp.14031

    authors: Helsby NA,Yong M,van Kan M,de Zoysa JR,Burns KE

    更新日期:2019-09-01 00:00:00

  • Topical minoxidil: cardiac effects in bald man.

    abstract::Systemic cardiovascular effects during chronic treatment with topical minoxidil vs placebo were evaluated using a double-blind, randomized design for two parallel groups (n = 20 for minoxidil, n = 15 for placebo). During 6 months of follow-up, blood pressure did not change, whereas minoxidil increased heart rate by 3-...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1111/j.1365-2125.1988.tb03410.x

    authors: Leenen FH,Smith DL,Unger WP

    更新日期:1988-10-01 00:00:00

  • Pharmacokinetic and -dynamic studies with a new anxiolytic, suriclone, utilizing EEG mapping and psychometry.

    abstract::1. In a double-blind, placebo-controlled, cross-over study, acute pharmacokinetic, neurophysiological and psychotropic effects of suriclone, a new cyclopyrrolone derivative, were investigated and compared with alprazolam. 2. Fifteen normal young volunteers received randomized oral single doses of placebo, 0.1, 0.2 and...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1111/j.1365-2125.1994.tb04254.x

    authors: Saletu B,Grünberger J,Linzmayer L,Semlitsch HV,Anderer P,Chwatal K

    更新日期:1994-02-01 00:00:00

  • Quality of requests for serum digoxin concentrations: experience from an Australian regional health service.

    abstract:WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT:* Therapeutic drug monitoring of serum digoxin concentrations (SDC) is considered useful in enhancing the therapeutic benefits of digoxin and minimizing the incidence of adverse drug reactions. * The quality of requests for SDC has been reported to be generally unsatisfactory. H...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.2006.02802.x

    authors: Ellington C,Grgurinovich N,Miners JO,Mangoni AA

    更新日期:2007-05-01 00:00:00